[1] Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)[J]. Neurol Med Chir (Tokyo), 2012, 52:245-266. [2] Wanebo JE, Zabramski JM, Spetzler RF. Superficial temporal artery-to-middle cerebral artery bypass grafting for cerebral revascularization[J]. Neurosurgery, 2004, 55:395-398. [3] Liu JJ, Steinberg GK. Direct versus indirect bypass for moyamoya disease[J]. Neurosurg Clin N Am, 2017, 28:361-374. [4] Shen W, Xu B, Li H, Gao X, Liao Y, Shi W, Zhao R, Zhang Y. Enlarged encephalo-duro-myo-synangiosis treatment for moyamoya disease in young children[J]. World Neurosurg, 2017, 106:9-16. [5] Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults[J]. J Neurosurg, 2018, 128:793-799. [6] Uchino H, Kim JH, Fujima N, Kazumata K, Ito M, Nakayama N, Kuroda S, Houkin K. Synergistic interactions between direct and indirect bypasses in combined procedures:the significance of indirect bypasses in moyamoya disease[J]. Neurosurgery, 2017, 80:201-209. [7] Chen Z, Zhang L, Qu J, Wu Y, Mao G, Zhu X, Zhu J. Clinical analysis of combined revascularization in treating ischemic moyamoya disease in adults[J]. Neurochirurgie, 2018, 64:49-52. [8] Rashad S, Fujimura M, Niizuma K, Endo H, Tominaga T. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery:single institute experience with surgical and perioperative management[J]. Neurosurg Rev, 2016, 39:615-623. [9] Patel NN, Mangano FT, Klimo P Jr. Indirect revascularization techniques for treating moyamoya disease[J]. Neurosurg Clin N Am, 2010, 21:553-563. [10] Li Q, Gao Y, Xin W, Zhou Z, Rong H, Qin Y, Li K, Zhou Y, Wang J, Xiong J, Dong X, Yang M, Liu Y, Shen J, Wang G, Song A, Zhang J. Meta-analysis of prognosis of different treatments for symptomatic moyamoya disease[J]. World Neurosurg, 2019, 127:354-361. [11] Wouters A, Smets I, Van den Noortgate W, Steinberg GK, Lemmens R. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease:a meta-analysis[J]. Acta Neurol Belg, 2019, 119:305-313. [12] Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic complications in patients with moyamoya disease[J]. J Neurosurg, 2005, 103(5 Suppl):433-438. [13] Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, Zhao J. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease[J]. J Neurosurg, 2018.[Epub ahead of print] [14] Yu J, Zhang J, Li J, Zhang J, Chen J. Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease:systematic review and meta-analysis[J]. World Neurosurg, 2020, 135:357-366.e4. [15] Li X, Huang Z, Wu MX, Zhang D. Effect of adventitial dissection of superficial temporal artery on the outcome of superficial temporal artery-middle cerebral artery bypass in moyamoya disease[J]. Aging Dis, 2017, 8:384-391. [16] Jussen D, Zdunczyk A, Schmidt S, Rösler J, Buchert R, Julkunen P, Karhu J, Brandt S, Picht T, Vajkoczy P. Motor plasticity after extra-intracranial bypass surgery in occlusive cerebrovascular disease[J]. Neurology, 2016, 87:27-35. [17] Funaki T, Takahashi JC, Takagi Y, Kikuchi T, Yoshida K, Mitsuhara T, Kataoka H, Okada T, Fushimi Y, Miyamoto S. Unstable moyamoya disease:clinical features and impact on perioperative ischemic complications[J]. J Neurosurg, 2015, 122:400-407. [18] Zhang Y, Bao XY, Duan L, Yang WZ, Li DS, Zhang ZS, Han C, Zhao F, Zhang Q, Wang QN. Encephaloduroarteriosynangiosis for pediatric moyamoya disease:long-term follow-up of 100 cases at a single center[J]. J Neurosurg Pediatr, 2018, 22:173-180. [19] Rosch KS, Mostofsky S. Development of the frontal lobe[J]. Handb Clin Neurol, 2019, 163:351-367. [20] Fellows LK. The functions of the frontal lobes:evidence from patients with focal brain damage[J]. Handb Clin Neurol, 2019, 163:19-34. |